连接COPD和心血管疾病的生物途径和机制
Beatrice Ragnoli1, Fausto Chiazza2, Giovanni Tarsi3
1SCDU Pneumologia, Ospedale S. Andrea, ASL VC, Vercelli, Italy.
Therapeutic advances in chronic disease
|March 31, 2025
概括
慢性阻塞性肺病 (COPD) 显著增加了心血管疾病 (CVD) 的风险. 炎症和低氧化等共享途径将COPD和心血管疾病联系在一起,影响患者的治疗结果.
科学领域:
- 心脏病学 心脏病学
- 肺部病理学 肺部病理学
- 老年学是一门学科.
背景情况:
- 心血管疾病 (CVD) 是慢性阻塞性肺病 (COPD) 患者的主要死亡原因.
- 肺功能下降,包括1秒内强制呼吸量 (FEV1),与心血管死亡率增加有关.
- 慢性肺炎患者的低氧化,炎症,氧化压力和高通胀可能会导致亚临床心血管参与.
研究的目的:
- 审查目前对COPD和心血管疾病 (CVD) 的同时发生的理解.
- 专注于共同的生物学途径和机制,这两种情况的基础.
主要方法:
- 这项研究是对现有文献的叙述性审查.
- 它综合了关于COPD和CVD之间的相互作用的当前知识.
主要成果:
- 老龄化通过诸如降低β-上腺素反应能力和增加血管硬等机制加剧心血管风险.
- 衰老,遗传因素和其他风险因素之间的相互作用有助于COPD患者心血管疾病的高患病率.
- 导致COPD和CVD之间的关联的确切机制在很大程度上是未知的.
结论:
- 慢性肺炎和心血管疾病经常同时存在,导致患者的治疗结果较差.
- 了解共享的生物通路对于管理患有这两种疾病的患者至关重要.
- 需要进一步的研究来阐明将COPD和CVD联系在一起的复杂机制.
更多相关视频
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
COPD: Pathogenesis and Clinical Features
202
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
202
Chronic Obstructive Pulmonary Disease
1.1K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.1K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.7K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
COPD: Management Using Bronchodilators and Corticosteroids
148
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
148


